knee osteoarthritis knee osteoarthritis walker physiotherapy
Conditions
Interventions
KOA participants recieve standard physiotherapy by professional Physical therapy for 12 weeks.,KOA participants using a modified walker in daily activities for 12 weeks.,KOA patients no treament for 1
Experimental Other,Active Comparator Device,Active Comparator No treatment
Physiotherapy combined with modified walker for KOA patient,modified walker for KOA patient,KOA patient control
Sponsors
Research Grant of Burapha University through National Research Council of Thailand
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Male or female participants aged over 50 years. 2. Clinical diagnosis of knee osteoarthritis based on the American College of Rheumatology (ACR) criteria, as outlined by Heidari B. (2011) in Caspian Journal of Internal Medicine. 3. Ability to ambulate independently or with the use of an assistive device. 4. No history of receiving physical therapy or structured knee osteoarthritis education within the 3 months prior to enrollment in the study. 5. Willingness and ability to comply with the assigned intervention schedule if randomized into a treatment group.
Exclusion criteria
Exclusion criteria: Exclusion Criteria Prior diagnosis of rheumatoid arthritis or gout. Inability to communicate or participate in physical assessments. Uncorrectable visual impairments (e.g., advanced cataracts or diabetic retinopathy). 1. Uncontrolled hypertension at the time of screening. 2. Known allergy to surface electromyography (sEMG) electrode adhesives. 3. High risk for exercise participation, defined as: 4. Classified as high risk based on the American College of Sports 1) Medicine (ACSM) pre-participation screening. 2) Moderate cardiovascular risk (score >2 on CVD Risk Factor Assessment), with physician judgment deeming the participant unsuitable for the study's physical testing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biomarker Before and 12 weeks after intervention Serum Biomarker,Ultrasound imaging Before and 12 weeks after intervention lower extremity muscle morphology,calf circumference Before and 12 weeks after intervention calf circumference,Knee Outcome Score Before and 12 weeks after intervention Knee Osteoarthritis Outcome Score (KOOS),pain score Before and 12 weeks after intervention visual analogue score for pain ,Kinesiophobia Before and 12 weeks after intervention Tampa Scale for Kinesiophobia,Falls Efficacy Scale Before and 12 weeks after intervention Falls Efficacy Scale,stress Before and 12 weeks after intervention Thai version of 10-Item Perceived Stress Scale-10,Physical activity Before and 12 weeks after intervention Global Physical Activity Questionnaire: GPAQ,sarcopenia screening Before and 12 weeks after intervention Strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) questionnaire,body composition Before and 12 weeks after intervention inbody,muscle activation Before and 12 weeks after intervention surface Electromyography (EMG),knee extension-flexion strength Before and 12 weeks after intervention Biodex sytem 4Pro,hand grip strength Before and 12 weeks after intervention Hand-grip dynamometer,gait speed Before and 12 weeks after intervention 10 meter walk test ,knee score Before and 12 weeks after intervention Oxford knee score ,30 second Chair Test Before and 12 weeks after intervention 30 second Chair Test,40 meter fast paced walk test Before and 12 weeks after intervention 40 meter fast paced walk test,Stair climb test Before and 12 weeks after intervention Stair climb test | — |
Secondary
| Measure | Time frame |
|---|---|
| lower limbs range of motion Before and 12 weeks after intervention range of motion | — |
Countries
Thailand
Contacts
Public ContactSIRIRAT KIATKULANUSORN
Burapha University, Thailand
Outcome results
None listed